Cite
HARVARD Citation
Khalid, F. et al. (2017). A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis. International journal of neuroscience. pp. 396-403. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Khalid, F. et al. (2017). A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis. International journal of neuroscience. pp. 396-403. [Online].